Alpha Teknova (TKNO) Other Non-Current Liabilities (2020 - 2024)
Alpha Teknova's (TKNO) quarterly Other Non-Current Liabilities came in at $10000.0 in Q4 2024, down 90.2% year-on-year from $102000.0 in Q1 2024, and down 66.67% on a QoQ basis from $30000.0 in Q3 2024.
Alpha Teknova (TKNO) Other Non-Current Liabilities (2020 - 2024) Analysis & Trends
Alpha Teknova (TKNO) has 5 years of Other Non-Current Liabilities data on file, last reported at $10000.0 in Q4 2024.
- On a quarterly basis, Other Non-Current Liabilities fell 90.2% year-over-year to $10000.0 in Q4 2024; TTM through Dec 2024 was $10000.0, a 90.2% decrease from a year earlier, with the FY2024 full-year figure at $10000.0, down 90.2% from the prior year.
- Other Non-Current Liabilities for Q4 2024 stood at $10000.0, down from $30000.0 in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for TKNO reached as high as $350000.0 in Q4 2020 and fell as low as $10000.0 in Q4 2024.
- Historically, Other Non-Current Liabilities has averaged $177000.0 across 5 years, with a median of $180000.0 in 2022.
- Across the five-year window, Other Non-Current Liabilities fell 22.0% in 2021 and slumped 90.2% in 2024, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $350000.0 in 2020, then decreased by 22.0% to $273000.0 in 2021, then sank by 30.04% to $191000.0 in 2022, then tumbled by 46.6% to $102000.0 in 2023, then slumped by 90.2% to $10000.0 in 2024.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $10000.0 in Q4 2024, $30000.0 in Q3 2024, and $54000.0 in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Alpha Teknova | 278.75 Mn | 260.97 Mn | 3.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 10,000.00 |
| Sep 30, 2024 | 30,000.00 |
| Jun 30, 2024 | 54,000.00 |
| Mar 31, 2024 | 78,000.00 |
| Dec 31, 2023 | 102,000.00 |
| Sep 30, 2023 | 125,000.00 |
| Jun 30, 2023 | 147,000.00 |
| Mar 31, 2023 | 169,000.00 |
| Dec 31, 2022 | 191,000.00 |
| Sep 30, 2022 | 212,000.00 |
| Jun 30, 2022 | 233,000.00 |
| Mar 31, 2022 | 253,000.00 |
| Dec 31, 2021 | 273,000.00 |
| Sep 30, 2021 | 293,000.00 |
| Jun 30, 2021 | 312,000.00 |
| Dec 31, 2020 | 350,000.00 |